Tools being developed by C-Path’s CURE Drug Repurposing Collaboratory will help incorporate adaptive platform trial protocols in clinical practice.Continue reading
Author Archive: Roxan Olivas
C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease
TUCSON, Ariz., November 9, 2021 — Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint collaboration to significantly promote data sharing and accelerate Leigh syndrome and other rare mitochondrial disease data incorporation into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading
Academic Innovation Leader and Experienced Scientist to Join C-Path’s PKD Consortium
Sorin Fedeles, Ph.D., MBA to serve as new Executive Director
TUCSON, Ariz., October 14, 2021 – Critical Path Institute (C-Path) today announced it has named Sorin Fedeles, Ph.D., MBA as Executive Director of its Polycystic Kidney Disease Outcomes Consortium (PKDOC), effective October 1, 2021.Continue reading
C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics
TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D., as Senior Advisor in Pediatrics working with its International Neonatal Consortium (INC) and advising on drug and device development in infants and children, effective immediately.Continue reading
Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program
C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform.Continue reading
C-Path and RARE-X Establish New Collaboration for Rare Disease Data Sharing
RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research
TUCSON, Ariz. and ALISO VIEJO, Calif., September 13, 2021 — Critical Path Institute (C-Path), who’s aim is to catalyze the development of new approaches that advance medical innovation and regulatory science, today announced a collaboration with RARE-X to improve ways researchers can access and analyze patient data. RARE-X is a nonprofit organization dedicated to enabling patient communities to collect, manage and share their de-identified data to advance research.Continue reading
Breaking Down Data Siloes: New Analytics Platform Sparks Opportunity for Rare Disease Field
C-Path, NORD and FDA have spent two years building the platform set to launch
Sept. 14 at the 2021 RDCA-DAP Workshop.Continue reading
C-Path Selects Arizona Financial Leader, former U.S. Embassy Finance Director, as CFO
TUCSON, Ariz., August 18, 2021— Critical Path Institute (C-Path) is pleased to announce that it has selected Kevin Perkins as its new Chief Financial Officer, effective August 9, 2021.Continue reading
Digital Health Technologies Hold Key to New Parkinson’s Treatments
Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies.Continue reading
Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development ConsortiumContinue reading